Ostex and Metrika collaborating on OTC osteoporosis test development.
This article was originally published in The Tan Sheet
Executive Summary
OSTEX, METRIKA COLLABORATING ON OTC OSTEOPOROSIS TEST development. The two firms are working on a one-step disposable test based on Ostex' technology for detecting cross-linked N-Terminal Telopeptides (NTx), a specific degradation marker of type I bone collagen. A quantitative reading of bone resorption (loss) is made by measuring the level of NTx in a urine sample. An above-normal reading of bone resorption is associated with osteoporosis.